NCT06139393 - Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults | Biotech Hunter

Enrollment

765

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

August 18, 2025

Study Completion Date

September 4, 2025

Conditions

Gout With Hyperuricemia in Adults

Interventions

DRUG

HR091506 tablets + placebo of febuxostat tablets

HR091506 tablets 20mg qd + placebo of febuxostat tablets 20mg qd from Week 1 to 4, HR091506 tablets 40mg qd + placebo of febuxostat tablets 40mg qd from Week 5 to 28.

DRUG

febuxostat tablets + placebo of HR091506 tablets

febuxostat tablets 20mg qd + placebo of HR091506 tablets 20mg qd from Week 1 to 4, febuxostat tablets 40mg qd + placebo of HR091506 tablets 40mg qd from Week 5 to 28.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY